Systemic Front Line Therapy of Follicular Lymphoma: When, to Whom and How.

Mediterr J Hematol Infect Dis · 2016 · PMC5111519 · PMID 27872742

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

This result was confirmed by a Cochrane meta-analysis, 124 which showed a trend toward increased risk of secondary malignancies in patients receiving ASCT.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.